424 related articles for article (PubMed ID: 26308010)
1. Potential Bioactive Compounds from Seaweed for Diabetes Management.
Sharifuddin Y; Chin YX; Lim PE; Phang SM
Mar Drugs; 2015 Aug; 13(8):5447-91. PubMed ID: 26308010
[TBL] [Abstract][Full Text] [Related]
2. Seaweed-derived bioactives as potential energy regulators in obesity and type 2 diabetes.
Bermano G; Stoyanova T; Hennequart F; Wainwright CL
Adv Pharmacol; 2020; 87():205-256. PubMed ID: 32089234
[TBL] [Abstract][Full Text] [Related]
3. Antidiabetic Potential of Marine Brown Algae-a Mini Review.
Gunathilaka TL; Samarakoon K; Ranasinghe P; Peiris LDC
J Diabetes Res; 2020; 2020():1230218. PubMed ID: 32377517
[TBL] [Abstract][Full Text] [Related]
4. Current anti-diabetic agents and their molecular targets: A review.
Kerru N; Singh-Pillay A; Awolade P; Singh P
Eur J Med Chem; 2018 May; 152():436-488. PubMed ID: 29751237
[TBL] [Abstract][Full Text] [Related]
5. Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2.
Lopes G; Andrade PB; Valentão P
Molecules; 2016 Dec; 22(1):. PubMed ID: 28042834
[TBL] [Abstract][Full Text] [Related]
6. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
Campbell RK
Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
[TBL] [Abstract][Full Text] [Related]
7. Uses of Papaya Leaf and Seaweed Supplementations for Controlling Glucose Homeostasis in Diabetes.
Nyakundi BB; Yang J
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047820
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular pleiotropic actions of DPP-4 inhibitors: a step at the cutting edge in understanding their additional therapeutic potentials.
Balakumar P; Dhanaraj SA
Cell Signal; 2013 Sep; 25(9):1799-803. PubMed ID: 23707531
[TBL] [Abstract][Full Text] [Related]
9. The multi-targets integrated fingerprinting for screening anti-diabetic compounds from a Chinese medicine Jinqi Jiangtang Tablet.
Chang YX; Ge AH; Donnapee S; Li J; Bai Y; Liu J; He J; Yang X; Song LJ; Zhang BL; Gao XM
J Ethnopharmacol; 2015 Apr; 164():210-22. PubMed ID: 25698248
[TBL] [Abstract][Full Text] [Related]
10. DPP-4 inhibitors in diabetic complications: role of DPP-4 beyond glucose control.
Bae EJ
Arch Pharm Res; 2016 Aug; 39(8):1114-28. PubMed ID: 27502601
[TBL] [Abstract][Full Text] [Related]
11. The role of seaweed bioactives in the control of digestion: implications for obesity treatments.
Chater PI; Wilcox MD; Houghton D; Pearson JP
Food Funct; 2015 Nov; 6(11):3420-7. PubMed ID: 26416783
[TBL] [Abstract][Full Text] [Related]
12. Hypoglycemic effect and mechanism of honokiol on type 2 diabetic mice.
Sun J; Fu X; Liu Y; Wang Y; Huo B; Guo Y; Gao X; Li W; Hu X
Drug Des Devel Ther; 2015; 9():6327-42. PubMed ID: 26674084
[TBL] [Abstract][Full Text] [Related]
13. Anti-diabetic effects of bioactive peptides: recent advances and clinical implications.
Acquah C; Dzuvor CKO; Tosh S; Agyei D
Crit Rev Food Sci Nutr; 2022; 62(8):2158-2171. PubMed ID: 33317324
[TBL] [Abstract][Full Text] [Related]
14. Phytopharmacological Strategies in the Management of Type 2 Diabetes
Duarte AM; Guarino MP; Barroso S; Gil MM
Foods; 2020 Mar; 9(3):. PubMed ID: 32131470
[TBL] [Abstract][Full Text] [Related]
15. Food protein hydrolysates as a source of dipeptidyl peptidase IV inhibitory peptides for the management of type 2 diabetes.
Power O; Nongonierma AB; Jakeman P; FitzGerald RJ
Proc Nutr Soc; 2014 Feb; 73(1):34-46. PubMed ID: 24131508
[TBL] [Abstract][Full Text] [Related]
16. [Incretin modulators, a new perspective in diabetes mellitus treatment].
Lupaşcu FG; Geangalău IM; Pânzariu A; Profire L
Rev Med Chir Soc Med Nat Iasi; 2012; 116(2):630-4. PubMed ID: 23077965
[TBL] [Abstract][Full Text] [Related]
17. Advances in the treatment of type 2 diabetes mellitus.
Israili ZH
Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic management of the older patient with type 2 diabetes mellitus.
Neumiller JJ; Setter SM
Am J Geriatr Pharmacother; 2009 Dec; 7(6):324-42. PubMed ID: 20129254
[TBL] [Abstract][Full Text] [Related]
19. Incretin therapies in the management of elderly patients with type 2 diabetes mellitus.
Bourdel-Marchasson I; Schweizer A; Dejager S
Hosp Pract (1995); 2011 Feb; 39(1):7-21. PubMed ID: 21441754
[TBL] [Abstract][Full Text] [Related]
20. The incretin system and its role in type 2 diabetes mellitus.
Holst JJ; Vilsbøll T; Deacon CF
Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
